Eli Lilly and Company operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Eli Lilly and Company with three other
companies in this sector in UNITED STATES :
sales of $24.38 billion
of which 100%
Bristol-Myers Squibb Company
of which 30%
was Prioritized Brands-Eliquis), and
Takeda Pharmaceutical Company Limited
of which 97%
was Pharmaceutical Business).
Eli Lilly and Company reported sales of $22.32 billion
December of 2019.
decrease of 9.1%
versus 2018, when the company's sales were $24.56 billion.